nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—ABCB1—Tamoxifen—pancreatic cancer	0.0812	0.133	CbGbCtD
Methylprednisolone—ABCB1—Gemcitabine—pancreatic cancer	0.07	0.115	CbGbCtD
Methylprednisolone—ABCB1—Erlotinib—pancreatic cancer	0.069	0.113	CbGbCtD
Methylprednisolone—ABCB1—Irinotecan—pancreatic cancer	0.0624	0.102	CbGbCtD
Methylprednisolone—CYP3A4—Tamoxifen—pancreatic cancer	0.0487	0.0797	CbGbCtD
Methylprednisolone—ABCB1—Docetaxel—pancreatic cancer	0.0457	0.0749	CbGbCtD
Methylprednisolone—ABCB1—Sunitinib—pancreatic cancer	0.0455	0.0745	CbGbCtD
Methylprednisolone—CYP3A4—Erlotinib—pancreatic cancer	0.0414	0.0678	CbGbCtD
Methylprednisolone—CYP3A4—Irinotecan—pancreatic cancer	0.0374	0.0612	CbGbCtD
Methylprednisolone—ABCB1—Doxorubicin—pancreatic cancer	0.0341	0.0558	CbGbCtD
Methylprednisolone—CYP3A4—Docetaxel—pancreatic cancer	0.0274	0.0449	CbGbCtD
Methylprednisolone—CYP3A4—Sunitinib—pancreatic cancer	0.0273	0.0447	CbGbCtD
Methylprednisolone—CYP3A4—Doxorubicin—pancreatic cancer	0.0204	0.0334	CbGbCtD
Methylprednisolone—Hypotension—Irinotecan—pancreatic cancer	0.00034	0.000872	CcSEcCtD
Methylprednisolone—Increased appetite—Doxorubicin—pancreatic cancer	0.00034	0.000872	CcSEcCtD
Methylprednisolone—Affect lability—Epirubicin—pancreatic cancer	0.00034	0.000871	CcSEcCtD
Methylprednisolone—Dizziness—Erlotinib—pancreatic cancer	0.000337	0.000865	CcSEcCtD
Methylprednisolone—Hypotension—Gemcitabine—pancreatic cancer	0.000331	0.000849	CcSEcCtD
Methylprednisolone—Eye disorder—Docetaxel—pancreatic cancer	0.000331	0.000848	CcSEcCtD
Methylprednisolone—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00033	0.000846	CcSEcCtD
Methylprednisolone—Insomnia—Irinotecan—pancreatic cancer	0.000329	0.000844	CcSEcCtD
Methylprednisolone—Cardiac disorder—Docetaxel—pancreatic cancer	0.000328	0.000842	CcSEcCtD
Methylprednisolone—Cardiac arrest—Epirubicin—pancreatic cancer	0.000328	0.000841	CcSEcCtD
Methylprednisolone—Vomiting—Tamoxifen—pancreatic cancer	0.000328	0.000841	CcSEcCtD
Methylprednisolone—Cardiac failure—Doxorubicin—pancreatic cancer	0.000327	0.000839	CcSEcCtD
Methylprednisolone—Mood swings—Epirubicin—pancreatic cancer	0.000327	0.000838	CcSEcCtD
Methylprednisolone—Paraesthesia—Irinotecan—pancreatic cancer	0.000327	0.000838	CcSEcCtD
Methylprednisolone—Hypotension—Fluorouracil—pancreatic cancer	0.000325	0.000835	CcSEcCtD
Methylprednisolone—Hypersensitivity—Sunitinib—pancreatic cancer	0.000325	0.000834	CcSEcCtD
Methylprednisolone—Rash—Tamoxifen—pancreatic cancer	0.000325	0.000834	CcSEcCtD
Methylprednisolone—Dermatitis—Tamoxifen—pancreatic cancer	0.000325	0.000833	CcSEcCtD
Methylprednisolone—Vomiting—Erlotinib—pancreatic cancer	0.000324	0.000832	CcSEcCtD
Methylprednisolone—Headache—Tamoxifen—pancreatic cancer	0.000323	0.000828	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000323	0.000828	CcSEcCtD
Methylprednisolone—Rash—Erlotinib—pancreatic cancer	0.000322	0.000825	CcSEcCtD
Methylprednisolone—Dermatitis—Erlotinib—pancreatic cancer	0.000321	0.000824	CcSEcCtD
Methylprednisolone—Angiopathy—Docetaxel—pancreatic cancer	0.000321	0.000823	CcSEcCtD
Methylprednisolone—Insomnia—Gemcitabine—pancreatic cancer	0.00032	0.000822	CcSEcCtD
Methylprednisolone—Dyspepsia—Irinotecan—pancreatic cancer	0.00032	0.000821	CcSEcCtD
Methylprednisolone—Immune system disorder—Docetaxel—pancreatic cancer	0.00032	0.00082	CcSEcCtD
Methylprednisolone—Headache—Erlotinib—pancreatic cancer	0.000319	0.00082	CcSEcCtD
Methylprednisolone—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000319	0.000819	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000319	0.000818	CcSEcCtD
Methylprednisolone—Paraesthesia—Gemcitabine—pancreatic cancer	0.000318	0.000816	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000317	0.000814	CcSEcCtD
Methylprednisolone—Asthenia—Sunitinib—pancreatic cancer	0.000317	0.000813	CcSEcCtD
Methylprednisolone—Arrhythmia—Docetaxel—pancreatic cancer	0.000316	0.000811	CcSEcCtD
Methylprednisolone—Insomnia—Fluorouracil—pancreatic cancer	0.000315	0.000808	CcSEcCtD
Methylprednisolone—Affect lability—Doxorubicin—pancreatic cancer	0.000314	0.000806	CcSEcCtD
Methylprednisolone—Fatigue—Irinotecan—pancreatic cancer	0.000314	0.000804	CcSEcCtD
Methylprednisolone—Paraesthesia—Fluorouracil—pancreatic cancer	0.000313	0.000802	CcSEcCtD
Methylprednisolone—Pruritus—Sunitinib—pancreatic cancer	0.000312	0.000801	CcSEcCtD
Methylprednisolone—Breast disorder—Epirubicin—pancreatic cancer	0.000312	0.0008	CcSEcCtD
Methylprednisolone—Mental disorder—Docetaxel—pancreatic cancer	0.00031	0.000795	CcSEcCtD
Methylprednisolone—Malnutrition—Docetaxel—pancreatic cancer	0.000308	0.00079	CcSEcCtD
Methylprednisolone—Erythema—Docetaxel—pancreatic cancer	0.000308	0.00079	CcSEcCtD
Methylprednisolone—Dyspepsia—Fluorouracil—pancreatic cancer	0.000307	0.000786	CcSEcCtD
Methylprednisolone—Nausea—Tamoxifen—pancreatic cancer	0.000306	0.000785	CcSEcCtD
Methylprednisolone—Fatigue—Gemcitabine—pancreatic cancer	0.000305	0.000783	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000304	0.00078	CcSEcCtD
Methylprednisolone—Muscular weakness—Epirubicin—pancreatic cancer	0.000304	0.00078	CcSEcCtD
Methylprednisolone—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000304	0.000779	CcSEcCtD
Methylprednisolone—Nausea—Erlotinib—pancreatic cancer	0.000303	0.000777	CcSEcCtD
Methylprednisolone—Mood swings—Doxorubicin—pancreatic cancer	0.000302	0.000776	CcSEcCtD
Methylprednisolone—Diarrhoea—Sunitinib—pancreatic cancer	0.000302	0.000775	CcSEcCtD
Methylprednisolone—Abdominal distension—Epirubicin—pancreatic cancer	0.0003	0.00077	CcSEcCtD
Methylprednisolone—Feeling abnormal—Irinotecan—pancreatic cancer	0.0003	0.000769	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000297	0.000763	CcSEcCtD
Methylprednisolone—Pancreatitis—Epirubicin—pancreatic cancer	0.000292	0.00075	CcSEcCtD
Methylprednisolone—Dizziness—Sunitinib—pancreatic cancer	0.000292	0.000749	CcSEcCtD
Methylprednisolone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000292	0.000749	CcSEcCtD
Methylprednisolone—Breast disorder—Doxorubicin—pancreatic cancer	0.000288	0.00074	CcSEcCtD
Methylprednisolone—Abdominal pain—Irinotecan—pancreatic cancer	0.000287	0.000737	CcSEcCtD
Methylprednisolone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000287	0.000736	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000282	0.000722	CcSEcCtD
Methylprednisolone—Muscular weakness—Doxorubicin—pancreatic cancer	0.000282	0.000722	CcSEcCtD
Methylprednisolone—Vomiting—Sunitinib—pancreatic cancer	0.000281	0.00072	CcSEcCtD
Methylprednisolone—Rash—Sunitinib—pancreatic cancer	0.000278	0.000714	CcSEcCtD
Methylprednisolone—Dermatitis—Sunitinib—pancreatic cancer	0.000278	0.000713	CcSEcCtD
Methylprednisolone—Abdominal distension—Doxorubicin—pancreatic cancer	0.000278	0.000712	CcSEcCtD
Methylprednisolone—Urticaria—Fluorouracil—pancreatic cancer	0.000277	0.00071	CcSEcCtD
Methylprednisolone—Headache—Sunitinib—pancreatic cancer	0.000277	0.000709	CcSEcCtD
Methylprednisolone—Syncope—Docetaxel—pancreatic cancer	0.000276	0.000709	CcSEcCtD
Methylprednisolone—Weight increased—Epirubicin—pancreatic cancer	0.000271	0.000696	CcSEcCtD
Methylprednisolone—Loss of consciousness—Docetaxel—pancreatic cancer	0.000271	0.000694	CcSEcCtD
Methylprednisolone—Pancreatitis—Doxorubicin—pancreatic cancer	0.00027	0.000694	CcSEcCtD
Methylprednisolone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000268	0.000687	CcSEcCtD
Methylprednisolone—Convulsion—Docetaxel—pancreatic cancer	0.000267	0.000685	CcSEcCtD
Methylprednisolone—Hypertension—Docetaxel—pancreatic cancer	0.000266	0.000682	CcSEcCtD
Methylprednisolone—Infestation NOS—Epirubicin—pancreatic cancer	0.000266	0.000682	CcSEcCtD
Methylprednisolone—Infestation—Epirubicin—pancreatic cancer	0.000266	0.000682	CcSEcCtD
Methylprednisolone—Arthralgia—Docetaxel—pancreatic cancer	0.000262	0.000673	CcSEcCtD
Methylprednisolone—Myalgia—Docetaxel—pancreatic cancer	0.000262	0.000673	CcSEcCtD
Methylprednisolone—Nausea—Sunitinib—pancreatic cancer	0.000262	0.000673	CcSEcCtD
Methylprednisolone—Asthenia—Irinotecan—pancreatic cancer	0.000261	0.000669	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000261	0.000668	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00026	0.000668	CcSEcCtD
Methylprednisolone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000257	0.000658	CcSEcCtD
Methylprednisolone—Sweating—Epirubicin—pancreatic cancer	0.000255	0.000654	CcSEcCtD
Methylprednisolone—Asthenia—Gemcitabine—pancreatic cancer	0.000254	0.000652	CcSEcCtD
Methylprednisolone—Confusional state—Docetaxel—pancreatic cancer	0.000253	0.00065	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000251	0.000645	CcSEcCtD
Methylprednisolone—Weight increased—Doxorubicin—pancreatic cancer	0.000251	0.000644	CcSEcCtD
Methylprednisolone—Pruritus—Gemcitabine—pancreatic cancer	0.000251	0.000643	CcSEcCtD
Methylprednisolone—Infection—Docetaxel—pancreatic cancer	0.00025	0.000641	CcSEcCtD
Methylprednisolone—Diarrhoea—Irinotecan—pancreatic cancer	0.000249	0.000638	CcSEcCtD
Methylprednisolone—Shock—Docetaxel—pancreatic cancer	0.000247	0.000634	CcSEcCtD
Methylprednisolone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000247	0.000632	CcSEcCtD
Methylprednisolone—Pruritus—Fluorouracil—pancreatic cancer	0.000246	0.000632	CcSEcCtD
Methylprednisolone—Infestation NOS—Doxorubicin—pancreatic cancer	0.000246	0.000631	CcSEcCtD
Methylprednisolone—Infestation—Doxorubicin—pancreatic cancer	0.000246	0.000631	CcSEcCtD
Methylprednisolone—Tachycardia—Docetaxel—pancreatic cancer	0.000245	0.000629	CcSEcCtD
Methylprednisolone—Skin disorder—Docetaxel—pancreatic cancer	0.000244	0.000626	CcSEcCtD
Methylprednisolone—Bradycardia—Epirubicin—pancreatic cancer	0.000243	0.000623	CcSEcCtD
Methylprednisolone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000242	0.000622	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000241	0.000619	CcSEcCtD
Methylprednisolone—Dizziness—Irinotecan—pancreatic cancer	0.00024	0.000617	CcSEcCtD
Methylprednisolone—Haemoglobin—Epirubicin—pancreatic cancer	0.00024	0.000615	CcSEcCtD
Methylprednisolone—Rhinitis—Epirubicin—pancreatic cancer	0.000239	0.000614	CcSEcCtD
Methylprednisolone—Haemorrhage—Epirubicin—pancreatic cancer	0.000239	0.000612	CcSEcCtD
Methylprednisolone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000238	0.000611	CcSEcCtD
Methylprednisolone—Sweating—Doxorubicin—pancreatic cancer	0.000236	0.000605	CcSEcCtD
Methylprednisolone—Hypotension—Docetaxel—pancreatic cancer	0.000235	0.000603	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000235	0.000602	CcSEcCtD
Methylprednisolone—Vomiting—Irinotecan—pancreatic cancer	0.000231	0.000593	CcSEcCtD
Methylprednisolone—Dizziness—Fluorouracil—pancreatic cancer	0.00023	0.000591	CcSEcCtD
Methylprednisolone—Visual impairment—Epirubicin—pancreatic cancer	0.00023	0.00059	CcSEcCtD
Methylprednisolone—Rash—Irinotecan—pancreatic cancer	0.000229	0.000588	CcSEcCtD
Methylprednisolone—Dermatitis—Irinotecan—pancreatic cancer	0.000229	0.000588	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000229	0.000587	CcSEcCtD
Methylprednisolone—Headache—Irinotecan—pancreatic cancer	0.000228	0.000584	CcSEcCtD
Methylprednisolone—Insomnia—Docetaxel—pancreatic cancer	0.000227	0.000583	CcSEcCtD
Methylprednisolone—Paraesthesia—Docetaxel—pancreatic cancer	0.000226	0.000579	CcSEcCtD
Methylprednisolone—Vomiting—Gemcitabine—pancreatic cancer	0.000225	0.000578	CcSEcCtD
Methylprednisolone—Bradycardia—Doxorubicin—pancreatic cancer	0.000225	0.000577	CcSEcCtD
Methylprednisolone—Rash—Gemcitabine—pancreatic cancer	0.000223	0.000573	CcSEcCtD
Methylprednisolone—Dermatitis—Gemcitabine—pancreatic cancer	0.000223	0.000572	CcSEcCtD
Methylprednisolone—Eye disorder—Epirubicin—pancreatic cancer	0.000223	0.000572	CcSEcCtD
Methylprednisolone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000222	0.000569	CcSEcCtD
Methylprednisolone—Headache—Gemcitabine—pancreatic cancer	0.000222	0.000569	CcSEcCtD
Methylprednisolone—Cardiac disorder—Epirubicin—pancreatic cancer	0.000221	0.000568	CcSEcCtD
Methylprednisolone—Vomiting—Fluorouracil—pancreatic cancer	0.000221	0.000568	CcSEcCtD
Methylprednisolone—Rhinitis—Doxorubicin—pancreatic cancer	0.000221	0.000568	CcSEcCtD
Methylprednisolone—Dyspepsia—Docetaxel—pancreatic cancer	0.000221	0.000568	CcSEcCtD
Methylprednisolone—Haemorrhage—Doxorubicin—pancreatic cancer	0.000221	0.000566	CcSEcCtD
Methylprednisolone—Rash—Fluorouracil—pancreatic cancer	0.00022	0.000563	CcSEcCtD
Methylprednisolone—Dermatitis—Fluorouracil—pancreatic cancer	0.000219	0.000563	CcSEcCtD
Methylprednisolone—Headache—Fluorouracil—pancreatic cancer	0.000218	0.00056	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000217	0.000557	CcSEcCtD
Methylprednisolone—Fatigue—Docetaxel—pancreatic cancer	0.000217	0.000556	CcSEcCtD
Methylprednisolone—Angiopathy—Epirubicin—pancreatic cancer	0.000217	0.000555	CcSEcCtD
Methylprednisolone—Nausea—Irinotecan—pancreatic cancer	0.000216	0.000554	CcSEcCtD
Methylprednisolone—Immune system disorder—Epirubicin—pancreatic cancer	0.000216	0.000553	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000215	0.000552	CcSEcCtD
Methylprednisolone—Arrhythmia—Epirubicin—pancreatic cancer	0.000213	0.000547	CcSEcCtD
Methylprednisolone—Visual impairment—Doxorubicin—pancreatic cancer	0.000213	0.000546	CcSEcCtD
Methylprednisolone—Nausea—Gemcitabine—pancreatic cancer	0.00021	0.00054	CcSEcCtD
Methylprednisolone—Mental disorder—Epirubicin—pancreatic cancer	0.000209	0.000536	CcSEcCtD
Methylprednisolone—Malnutrition—Epirubicin—pancreatic cancer	0.000208	0.000533	CcSEcCtD
Methylprednisolone—Erythema—Epirubicin—pancreatic cancer	0.000208	0.000533	CcSEcCtD
Methylprednisolone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000207	0.000531	CcSEcCtD
Methylprednisolone—Nausea—Fluorouracil—pancreatic cancer	0.000207	0.000531	CcSEcCtD
Methylprednisolone—Eye disorder—Doxorubicin—pancreatic cancer	0.000206	0.000529	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000206	0.000527	CcSEcCtD
Methylprednisolone—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000205	0.000526	CcSEcCtD
Methylprednisolone—Angiopathy—Doxorubicin—pancreatic cancer	0.0002	0.000514	CcSEcCtD
Methylprednisolone—Immune system disorder—Doxorubicin—pancreatic cancer	0.000199	0.000512	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000199	0.000511	CcSEcCtD
Methylprednisolone—Abdominal pain—Docetaxel—pancreatic cancer	0.000199	0.00051	CcSEcCtD
Methylprednisolone—Arrhythmia—Doxorubicin—pancreatic cancer	0.000197	0.000506	CcSEcCtD
Methylprednisolone—Mental disorder—Doxorubicin—pancreatic cancer	0.000193	0.000496	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000193	0.000494	CcSEcCtD
Methylprednisolone—Malnutrition—Doxorubicin—pancreatic cancer	0.000192	0.000493	CcSEcCtD
Methylprednisolone—Erythema—Doxorubicin—pancreatic cancer	0.000192	0.000493	CcSEcCtD
Methylprednisolone—Malaise—Epirubicin—pancreatic cancer	0.000187	0.000481	CcSEcCtD
Methylprednisolone—Vertigo—Epirubicin—pancreatic cancer	0.000187	0.000479	CcSEcCtD
Methylprednisolone—Syncope—Epirubicin—pancreatic cancer	0.000186	0.000478	CcSEcCtD
Methylprednisolone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000185	0.000475	CcSEcCtD
Methylprednisolone—Loss of consciousness—Epirubicin—pancreatic cancer	0.000183	0.000468	CcSEcCtD
Methylprednisolone—Asthenia—Docetaxel—pancreatic cancer	0.00018	0.000463	CcSEcCtD
Methylprednisolone—Convulsion—Epirubicin—pancreatic cancer	0.00018	0.000462	CcSEcCtD
Methylprednisolone—Hypertension—Epirubicin—pancreatic cancer	0.000179	0.00046	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000178	0.000458	CcSEcCtD
Methylprednisolone—Pruritus—Docetaxel—pancreatic cancer	0.000178	0.000456	CcSEcCtD
Methylprednisolone—Arthralgia—Epirubicin—pancreatic cancer	0.000177	0.000454	CcSEcCtD
Methylprednisolone—Myalgia—Epirubicin—pancreatic cancer	0.000177	0.000454	CcSEcCtD
Methylprednisolone—Anxiety—Epirubicin—pancreatic cancer	0.000176	0.000452	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000176	0.000451	CcSEcCtD
Methylprednisolone—Discomfort—Epirubicin—pancreatic cancer	0.000175	0.000448	CcSEcCtD
Methylprednisolone—Malaise—Doxorubicin—pancreatic cancer	0.000173	0.000445	CcSEcCtD
Methylprednisolone—Vertigo—Doxorubicin—pancreatic cancer	0.000173	0.000443	CcSEcCtD
Methylprednisolone—Syncope—Doxorubicin—pancreatic cancer	0.000172	0.000442	CcSEcCtD
Methylprednisolone—Diarrhoea—Docetaxel—pancreatic cancer	0.000172	0.000441	CcSEcCtD
Methylprednisolone—Confusional state—Epirubicin—pancreatic cancer	0.000171	0.000439	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00017	0.000435	CcSEcCtD
Methylprednisolone—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000169	0.000433	CcSEcCtD
Methylprednisolone—Infection—Epirubicin—pancreatic cancer	0.000168	0.000432	CcSEcCtD
Methylprednisolone—Shock—Epirubicin—pancreatic cancer	0.000167	0.000428	CcSEcCtD
Methylprednisolone—Convulsion—Doxorubicin—pancreatic cancer	0.000167	0.000427	CcSEcCtD
Methylprednisolone—Nervous system disorder—Epirubicin—pancreatic cancer	0.000166	0.000427	CcSEcCtD
Methylprednisolone—Dizziness—Docetaxel—pancreatic cancer	0.000166	0.000426	CcSEcCtD
Methylprednisolone—Hypertension—Doxorubicin—pancreatic cancer	0.000166	0.000426	CcSEcCtD
Methylprednisolone—Tachycardia—Epirubicin—pancreatic cancer	0.000165	0.000424	CcSEcCtD
Methylprednisolone—Skin disorder—Epirubicin—pancreatic cancer	0.000165	0.000422	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000164	0.00042	CcSEcCtD
Methylprednisolone—Arthralgia—Doxorubicin—pancreatic cancer	0.000164	0.00042	CcSEcCtD
Methylprednisolone—Myalgia—Doxorubicin—pancreatic cancer	0.000164	0.00042	CcSEcCtD
Methylprednisolone—Anxiety—Doxorubicin—pancreatic cancer	0.000163	0.000418	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000163	0.000417	CcSEcCtD
Methylprednisolone—Discomfort—Doxorubicin—pancreatic cancer	0.000162	0.000415	CcSEcCtD
Methylprednisolone—Vomiting—Docetaxel—pancreatic cancer	0.00016	0.00041	CcSEcCtD
Methylprednisolone—Rash—Docetaxel—pancreatic cancer	0.000158	0.000407	CcSEcCtD
Methylprednisolone—Hypotension—Epirubicin—pancreatic cancer	0.000158	0.000406	CcSEcCtD
Methylprednisolone—Dermatitis—Docetaxel—pancreatic cancer	0.000158	0.000406	CcSEcCtD
Methylprednisolone—Confusional state—Doxorubicin—pancreatic cancer	0.000158	0.000406	CcSEcCtD
Methylprednisolone—Headache—Docetaxel—pancreatic cancer	0.000157	0.000404	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000157	0.000402	CcSEcCtD
Methylprednisolone—Infection—Doxorubicin—pancreatic cancer	0.000156	0.0004	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000154	0.000396	CcSEcCtD
Methylprednisolone—Shock—Doxorubicin—pancreatic cancer	0.000154	0.000396	CcSEcCtD
Methylprednisolone—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000154	0.000395	CcSEcCtD
Methylprednisolone—Insomnia—Epirubicin—pancreatic cancer	0.000153	0.000393	CcSEcCtD
Methylprednisolone—Tachycardia—Doxorubicin—pancreatic cancer	0.000153	0.000393	CcSEcCtD
Methylprednisolone—Skin disorder—Doxorubicin—pancreatic cancer	0.000152	0.000391	CcSEcCtD
Methylprednisolone—Paraesthesia—Epirubicin—pancreatic cancer	0.000152	0.000391	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000152	0.000389	CcSEcCtD
Methylprednisolone—Nausea—Docetaxel—pancreatic cancer	0.000149	0.000383	CcSEcCtD
Methylprednisolone—Dyspepsia—Epirubicin—pancreatic cancer	0.000149	0.000383	CcSEcCtD
Methylprednisolone—Hypotension—Doxorubicin—pancreatic cancer	0.000147	0.000376	CcSEcCtD
Methylprednisolone—Fatigue—Epirubicin—pancreatic cancer	0.000146	0.000375	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000143	0.000367	CcSEcCtD
Methylprednisolone—Insomnia—Doxorubicin—pancreatic cancer	0.000142	0.000364	CcSEcCtD
Methylprednisolone—Paraesthesia—Doxorubicin—pancreatic cancer	0.000141	0.000361	CcSEcCtD
Methylprednisolone—Feeling abnormal—Epirubicin—pancreatic cancer	0.00014	0.000358	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000139	0.000356	CcSEcCtD
Methylprednisolone—Dyspepsia—Doxorubicin—pancreatic cancer	0.000138	0.000354	CcSEcCtD
Methylprednisolone—Fatigue—Doxorubicin—pancreatic cancer	0.000135	0.000347	CcSEcCtD
Methylprednisolone—Urticaria—Epirubicin—pancreatic cancer	0.000135	0.000346	CcSEcCtD
Methylprednisolone—Abdominal pain—Epirubicin—pancreatic cancer	0.000134	0.000344	CcSEcCtD
Methylprednisolone—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000129	0.000332	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000128	0.000329	CcSEcCtD
Methylprednisolone—Hypersensitivity—Epirubicin—pancreatic cancer	0.000125	0.00032	CcSEcCtD
Methylprednisolone—Urticaria—Doxorubicin—pancreatic cancer	0.000125	0.00032	CcSEcCtD
Methylprednisolone—Abdominal pain—Doxorubicin—pancreatic cancer	0.000124	0.000318	CcSEcCtD
Methylprednisolone—Asthenia—Epirubicin—pancreatic cancer	0.000122	0.000312	CcSEcCtD
Methylprednisolone—Pruritus—Epirubicin—pancreatic cancer	0.00012	0.000308	CcSEcCtD
Methylprednisolone—Diarrhoea—Epirubicin—pancreatic cancer	0.000116	0.000298	CcSEcCtD
Methylprednisolone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000116	0.000297	CcSEcCtD
Methylprednisolone—Asthenia—Doxorubicin—pancreatic cancer	0.000113	0.000289	CcSEcCtD
Methylprednisolone—Dizziness—Epirubicin—pancreatic cancer	0.000112	0.000288	CcSEcCtD
Methylprednisolone—Pruritus—Doxorubicin—pancreatic cancer	0.000111	0.000285	CcSEcCtD
Methylprednisolone—Vomiting—Epirubicin—pancreatic cancer	0.000108	0.000277	CcSEcCtD
Methylprednisolone—Diarrhoea—Doxorubicin—pancreatic cancer	0.000107	0.000275	CcSEcCtD
Methylprednisolone—Rash—Epirubicin—pancreatic cancer	0.000107	0.000274	CcSEcCtD
Methylprednisolone—Dermatitis—Epirubicin—pancreatic cancer	0.000107	0.000274	CcSEcCtD
Methylprednisolone—Headache—Epirubicin—pancreatic cancer	0.000106	0.000272	CcSEcCtD
Methylprednisolone—Dizziness—Doxorubicin—pancreatic cancer	0.000104	0.000266	CcSEcCtD
Methylprednisolone—Nausea—Epirubicin—pancreatic cancer	0.000101	0.000258	CcSEcCtD
Methylprednisolone—Vomiting—Doxorubicin—pancreatic cancer	9.97e-05	0.000256	CcSEcCtD
Methylprednisolone—Rash—Doxorubicin—pancreatic cancer	9.89e-05	0.000254	CcSEcCtD
Methylprednisolone—Dermatitis—Doxorubicin—pancreatic cancer	9.88e-05	0.000254	CcSEcCtD
Methylprednisolone—Headache—Doxorubicin—pancreatic cancer	9.83e-05	0.000252	CcSEcCtD
Methylprednisolone—Nausea—Doxorubicin—pancreatic cancer	9.32e-05	0.000239	CcSEcCtD
